On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Pauline Wimberger

ResearcherPublications, citations & collaboration network

Pauline Wimberger is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Pauline Wimberger have?

ScholarIQindexed works

Pauline Wimberger has 889 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Pauline Wimberger have?

ScholarIQcitation count

Pauline Wimberger has 23,817 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Pauline Wimberger?

ScholarIQh-index

Pauline Wimberger has an h-index of 67 in OpenAlex.

What is the i10-index of Pauline Wimberger?

ScholarIQi10-index

Pauline Wimberger has an i10-index of 219 in OpenAlex.

What is the ORCID of Pauline Wimberger?

ScholarIQorcid

The ORCID for Pauline Wimberger is on the source record.

What is the OpenAlex record for Pauline Wimberger?

ScholarIQopenalex

The OpenAlex for Pauline Wimberger is on the source record.

What are the most-cited papers on Pauline Wimberger?

ScholarIQmost cited works
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A. Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti, Christina Fotopoulou, Antonio González-Martı́n, Sigurd Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A. Nout, D. O’Donnell, Denis Querleu, Maria Rosaria Raspollini, Jalid Sehouli, Alina Sturdza, Alexandra Taylor, Anneke M. Westermann, Pauline Wimberger, Nicoletta Colombo, François Planchamp, Carien L. Creutzberg
International Journal of Gynecological Cancer. 20201,972 CitationsOPEN ACCESS
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Léary, Robert W. Holloway, Margarita Amenedo, Peter C.C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Jesús García-Donás, Elizabeth M. Swisher, Anne Floquet, Gottfried E. Konecny, Iain A. McNeish, Clare L. Scott, T. Cameron, Lara Maloney, Jeff Isaacson, Sandra Goble, Caroline A. Grace, Thomas C. Harding, Mitch Raponi, James Sun, Kevin Lin, Heidi Giordano, Jonathan A. Ledermann, Martin Buck, Andrew Dean, Michael Friedländer, Jeffrey C. Goh, Paul R. Harnett, Ganessan Kichenadasse, Clare L. Scott, Hannelore Denys, Luc Dirix, Ignace Vergote, Laurie Elit, Prafull Ghatage, Amit M. Oza, Marie Plante, Diane Provencher, Johanne I. Weberpals, Stephen Welch, Anne Floquet, Laurence Gladieff, Florence Joly, Alexandra Léary, Alain Lortholary, Jean‐Pierre Lotz, Jacques Médioni, Olivier Trédan, Benoît You, Ayşe Balat, Claudia Hänle, Petra Krabisch, Tanja Neunhöffer, Martin Pölcher, Pauline Wimberger, A Amit, Svetlana Kovel, Michelle Leviov, Tamar Safra, Ronnie Shapira‐Frommer, Salomon M. Stemmer, Alessandra Bologna, Nicoletta Colombo, Domenica Lorusso, Sandro Pignata, Roberto Sabbatini, Giovanni Scambia, Stefano Tamberi, Claudio Zamagni, Peter C.C. Fong, Anne O’Donnell, Margarita Amenedo, A. Casado Herráez, Jesús García-Donás, E.M. Guerra, Ana Oaknin, Isabel Palacio, Ignacio Romero, A Sanchez, Susana Banerjee, Andrew R. Clamp, Yvette Drew, Hani Gabra, D Jackson, JA Ledermann, Iain A. McNeish, C. A. Parkinson, Melanie Powell, Carol Aghajanian
The Lancet. 20171,721 CitationsOPEN ACCESS
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Éric Pujade-Lauraine, Felix Hilpert, B. Weber, Alexander Reuß, Andrés Poveda, Gunnar B. Kristensen, Roberto Sorio, Ignace Vergote, Petronella O. Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David T. Bollag, Isabelle Ray‐Coquard
Journal of Clinical Oncology. 20141,636 CitationsOPEN ACCESS
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
Carsten Denkert, Fenja Seither, Andreas Schneeweiß, Theresa Link, Jens‐Uwe Blohmer, Marianne Just, Pauline Wimberger, A Forberger, Hans Tesch, Christian Jackisch, Sabine Schmatloch, Mattea Reinisch, Erich Solomayer, Wolfgang Schmitt, Claus Hanusch, Peter A. Fasching, Kristina Lübbe, Christine Solbach, Jens Huober, Kerstin Rhiem, Frederik Marmé, Toralf Reimer, Marcus Schmidt, Bruno V. Sinn, Wolfgang Janni, Elmar Stickeler, Laura L. Michel, Oliver Stötzer, Eric Hahnen, Jenny Furlanetto, Sabine Seiler, Valentina Nekljudova, Michael Untch, Sibylle Loibl
The Lancet Oncology. 2021571 Citations
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
David Cibula, Daniela Fischerova, Richard Pötter, François Planchamp, Denis Querleu, Elisabeth Åvall‐Lundqvist, Christine Haie Meder, Christhardt Köhler, Fabio Landoni, Sigurd Lax, Jacob Christian Lindegaard, Umesh Mahantshetty, Patrice Mathevet, W. Glenn McCluggage, Mary McCormack, Raj Naik, Remi A. Nout, Sandro Pignata, Jordi Ponce, Francesco Raspagliesi, Alexandros Rodolakis, Karl Tamussino, Pauline Wimberger, Maria Rosaria Raspollini
International Journal of Gynecological Cancer. 2018482 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account